<DOC>
	<DOCNO>NCT00004151</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness acridine carboxamide treat patient advance non-small cell lung cancer treat surgery .</brief_summary>
	<brief_title>Acridine Carboxamide Treating Patients With Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine effect acridine carboxamide objective response , response rate , duration response patient unresectable , locally advanced , progressive metastatic non-small cell lung cancer . II . Determine toxicities pharmacokinetics regimen patient . OUTLINE : This multicenter study . Patients receive acridine carboxamide IV 24 hour 5 day . Treatment repeat every 3 week maximum 6 course absence disease progression unacceptable toxicity . Patients follow every 6 week disease progression commencement another treatment . PROJECTED ACCRUAL : A total 14-25 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven unresectable , locally advanced , progressive metastatic nonsmall cell lung cancer Not amenable curative surgery radiotherapy No prior first line chemotherapy metastatic advance disease At least 1 bidimensionally measurable target lesion CT scan No symptomatic brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 3 month Hematopoietic : WBC great 3,000/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 1.5 time upper limit normal ( ULN ) SGOT , SGPT , alkaline phosphatase great 2 time ULN ( 5 time ULN liver metastasis present ) Renal : Creatinine great 1.7 mg/dL Cardiovascular : No ischemic heart disease within past 6 month Normal 12 lead ECG Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No prior concurrent malignancy except cone biopsied carcinoma cervix adequately treat basal squamous cell skin cancer No unstable systemic disease active uncontrolled infection No psychological , familial , sociological , geographical condition could preclude compliance PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy Surgery : At least 2 week since prior major surgery Other : No concurrent anticancer agents No concurrent investigational therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>